Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Log ind
Få fuld adgang
Biotech-IgG Securities (publ) AB
AB
Bankrupt
Org 5590179437
Annan naturvetenskaplig och teknisk forskning och utveckling
·
NACE 7210
Stiftet 2015 · 11 år gammel
0 ansatte
Overvåg
Del
Sverige
/
Virksomheder
/
Research and experimental development on natural sciences and engineering
/
Biotech-IgG Securities (publ) AB
Overblik
Regnskaber
Personer & ejerskab
Relaterede virksomheder
Loading company…
Personer & ejerskab
Ledelse
Nuværende ledelse
Name
Role
Member since
Current (1)
HG
Hugo Glenn Renhult
Chief Executive Officer
Chief Executive Officer
2021
Tidligere (4)
KE
Karl Erik Göran Bringer
Audit
Audit
2021 – 2022
LG
Leif Gunnar Skarle
Audit
Audit
2023 – 2023
IT
Ivan Ticic
Chief Auditor
Chief Auditor
2022 – 2024
IE
Isabella Eva Rümmer
Audit
Audit
2021 – 2022
Bestyrelse
Bestyrelsestilsyn
Name
Role
Member since
Current (3)
JK
Johan Karl-Herbert Lee Backman
Board of Directors
Board of Directors
2021
PW
Per Wilhelm Wåhlin
Chairman
Chairman
2021
HG
Hugo Glenn Renhult
Board of Directors
Board of Directors
2021
Tidligere (2)
LG
Leif Gustaf Malmborg
Chairman
Chairman
2023 – 2023
IH
Ingemar Håkan Karlsson
Chairman
Chairman
2023 – 2023
Aktionærer
Pr. seneste årsrapport
Biotech-IgG Equity AB (publ) — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Biotech-IgG Equity AB (publ)
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Mere om Biotech-IgG Securities (publ) AB
Overblik →
Hovedtal, risikovurdering og virksomhedsresumé
Regnskaber & nøgletal →
Omsætning, EBITDA, balance og 5-års udvikling
Relaterede virksomheder →
Koncernstruktur, moder- og datterselskabsnetværk